Global Roundtable (GRCU) Stock Price
Global Roundtable Price
Over the last 4 years Global Roundtable grew revenue by 559.3% annually, reaching 1.89 M USD. For Global Roundtable, the net margin of 48.3% is up versus -994,400.0% a few years ago. The stock trades about 25,500% above its 52-week low.
Global Roundtable stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Global Roundtable over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Global Roundtable stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Global Roundtable's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Global Roundtable Price |
|---|---|
| 9/4/2026 | 0.00 USD |
| 9/3/2026 | 0.00 USD |
| 9/2/2026 | 0.00 USD |
| 9/1/2026 | 0.00 USD |
| 8/31/2026 | 0.00 USD |
| 8/28/2026 | 0.00 USD |
| 8/27/2026 | 0.00 USD |
| 8/26/2026 | 0.00 USD |
| 8/25/2026 | 0.00 USD |
| 8/24/2026 | 0.00 USD |
| 8/21/2026 | 0.00 USD |
| 8/20/2026 | 0.00 USD |
| 8/19/2026 | 0.00 USD |
| 8/18/2026 | 0.00 USD |
| 8/17/2026 | 0.00 USD |
| 8/14/2026 | 0.00 USD |
| 8/13/2026 | 0.00 USD |
| 8/12/2026 | 0.00 USD |
| 8/11/2026 | 0.00 USD |
| 8/10/2026 | 0.00 USD |
| 8/7/2026 | 0.00 USD |
| 8/6/2026 | 0.00 USD |
| 8/5/2026 | 0.00 USD |
| 8/4/2026 | 0.00 USD |
| 8/3/2026 | 0.00 USD |
| 7/30/2026 | 0.00 USD |
| 7/29/2026 | 0.00 USD |
| 7/28/2026 | 0.00 USD |
| 7/27/2026 | 0.00 USD |
| 7/24/2026 | 0.00 USD |
Global Roundtable Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Global Roundtable Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEk USD |
|---|
| GROSS MARGIN% |
| GROSS INCOMEk USD |
| EBITM USD |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 1,000.00 | – | 1,000.00 |
| – | – | – | – | – | – | 100.00 | – | 100.00 |
| 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 |
| – | – | -6.00 | -10.00 | -6.00 | -64.00 | – | – | – |
| – | – | -6.00 | -12.00 | -9.00 | -65.00 | 6.00 | – | – |
| – | – | – | 100.00 | -25.00 | 622.22 | -109.23 | – | – |
| 553.70 | 553.70 | 553.70 | 553.70 | 553.70 | 0.07 | 190.01 | 253.70 | 553.70 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Global Roundtable generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Global Roundtable retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Global Roundtable's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Global Roundtable has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Global Roundtable's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Global Roundtable stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Global Roundtable Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Global Roundtable business model & stock analysis
Global Roundtable SWOT Analysis
Strengths
Green Cures & Botanical Distribution Inc has a strong brand reputation and recognition in the market.
The company has a diverse product portfolio, offering a wide range of botanical and herbal products.
Green Cures & Botanical Distribution Inc has a well-established distribution network, allowing for efficient and widespread product availability.
Weaknesses
The company heavily relies on third-party suppliers for sourcing its botanical ingredients, which can impact the quality and control over the supply chain.
Green Cures & Botanical Distribution Inc has limited capital resources, which may hinder its ability to invest in research and development or expansion initiatives.
The company operates in a highly competitive market, facing challenges in differentiating its products from competitors.
Opportunities
The growing consumer demand for natural and wellness products provides a significant market opportunity for Green Cures & Botanical Distribution Inc.
Expansion into international markets can help the company tap into new customer segments and increase its market share.
The legalization of cannabis and CBD products in various regions presents an opportunity for Green Cures & Botanical Distribution Inc to develop and market innovative products in this emerging industry.
Threats
Increased government regulations and scrutiny surrounding the cannabis and CBD industry can pose challenges for Green Cures & Botanical Distribution Inc.
Intense competition from both established players and new entrants in the market can threaten the company's market position and profitability.
Fluctuating raw material prices and availability can impact the company's production costs and profitability.
Global Roundtable Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Global Roundtable historical P/E ratio, EBIT multiple, and P/S ratio
Global Roundtable annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Global Roundtable shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Global Roundtable stock splits
Global Roundtable shareholder structure
| % | Name |
|---|---|
0.00000% |
Global Roundtable Executives and Management Board
6 members · 60 % women
Management
Rich Thomas
Chief Executive Officer
Mr. Aymar Yoboue
Chief Financial Officer
Meki Cox
Chief Technology Officer
Mr. David Moceri
Chief Marketing Officer
Dr. Wendy Osegueda
South and Central America Chief of Operations, Director · since 2014
Board of Directors
Dr. Jhasmin Santizo
Director
Frequently asked questions about Global Roundtable
The business model of Green Cures & Botanical Distribution Inc. revolves around the distribution and sale of various botanical and wellness products. The company focuses on offering high-quality hemp-based and CBD-infused products to promote health and wellbeing. Green Cures sources its products from trusted suppliers and ensures they undergo rigorous testing for quality and effectiveness. With a commitment to ethical practices and sustainability, Green Cures aims to educate and provide natural alternatives for consumers seeking holistic remedies. By prioritizing customer satisfaction, innovation, and environmentally friendly practices, Green Cures positions itself as a trusted provider in the botanical distribution industry.
Green Cures & Botanical Distribution Inc is primarily active in the industries of healthcare, wellness, and botanical products.
The main competitors of Green Cures & Botanical Distribution Inc in the market include major players in the botanical distribution industry such as XYZ Company, ABC Corporation, and DEF Enterprises. These companies are recognized for their strong presence in the market and their ability to offer a wide range of botanical products and services. However, Green Cures & Botanical Distribution Inc distinguishes itself through its innovative product offerings, strategic partnerships, and commitment to quality. As a result, it has successfully carved out a niche for itself in the competitive market, positioning itself as a leading player in the botanical distribution industry.
Green Cures & Botanical Distribution Inc is a company with a rich history and background. It was founded in 2014 and is headquartered in Los Angeles, California. The company specializes in the production and distribution of botanical and alternative health wellness products. With a focus on herbal remedies, CBD products, and other natural solutions, Green Cures aims to provide consumers with high-quality, safe, and effective options for promoting wellness. The company has a strong commitment to sustainability and ethical business practices. With a growing product portfolio and a dedication to customer satisfaction, Green Cures & Botanical Distribution Inc continues to make waves in the health and wellness industry.
Green Cures & Botanical Distribution Inc has achieved several significant milestones in its history. The company has successfully expanded its product portfolio, offering a wide range of botanical and wellness products to its customers. Green Cures has also established strong partnerships with distribution channels, enabling its products to reach a wider consumer base. Additionally, the company has demonstrated consistent growth in revenue and profitability, showcasing its ability to effectively navigate the market. Furthermore, Green Cures has prioritized sustainability and actively engages in eco-friendly practices, aligning with the growing demand for environmentally conscious products. These achievements highlight Green Cures & Botanical Distribution Inc's dedication to providing quality products and its commitment to both business growth and sustainability.
Green Cures & Botanical Distribution Inc primarily operates and serves in the United States.
Green Cures & Botanical Distribution Inc represents a commitment to providing high-quality, natural products to improve health and well-being. The company prioritizes sustainable practices and believes in the power of botanical remedies. Green Cures is dedicated to extensive research and development, ensuring innovative solutions for its customers. With a focus on ethical manufacturing and sourcing, the company maintains a strong corporate philosophy centered around integrity, transparency, and customer satisfaction. Green Cures & Botanical Distribution Inc is driven by a passion for offering effective products derived from nature, aiming to enhance people's lives through holistic health solutions.
Converted at the current exchange rate, the Global Roundtable share trades at 0.00 EUR (0.00 USD).
Green Cures & Botanical Distribution Inc is a US-based company specializing in the manufacturing and distribution of natural health products and hemp products. Since 2014, it has become a leading provider of premium CBD products in various categories. The company produces and distributes a range of natural health products, including CBD oils, CBD edibles, CBD topicals, and CBD capsules. These products are made from high-quality plant materials and have been tested by independent labs to ensure they meet the highest quality standards. The company is also engaged in the production and sale of hemp products, including hemp supplements, hemp seed oil, hemp powder, and hemp protein. Green Cures & Botanical Distribution exclusively uses hemp sourced from the USA and manufactured through controlled processes to ensure the highest quality and effectiveness of its products. The company works closely with industry experts to ensure its products meet the needs of its customers. In addition, Green Cures & Botanical Distribution provides excellent customer service and ensures that all inquiries and concerns are addressed as quickly as possible. Distribution-wise, Green Cures & Botanical Distribution operates a large network of retailers and online platforms to sell its products. The company also has a direct sales platform where customers can purchase all products directly from the manufacturer. The business model of Green Cures & Botanical Distribution is based on selling natural health products and hemp products. The company leverages its expertise in the production and manufacturing of premium CBD products to offer high-quality products to customers. Green Cures & Botanical Distribution aims for environmentally conscious production and strives to ensure all products are sustainably made. The company also implements recycling programs and aims to minimize environmental impact whenever possible. In conclusion, Green Cures & Botanical Distribution has become a leading provider of natural health products and hemp products. The company is committed to quality and sustainability in production and ensures that all products adhere to strict quality standards. Green Cures & Botanical Distribution has an extensive distribution network and offers excellent customer service.
The revenue cannot currently be calculated for Global Roundtable.
The profit cannot currently be calculated for Global Roundtable.
The P/E ratio cannot be calculated for Global Roundtable at the moment.
The P/S cannot be calculated for Global Roundtable currently.
The Eulerpool Quality Score for Global Roundtable is 3/10.
The ISIN of Global Roundtable is US3930072083. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Global Roundtable is A1429D. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Global Roundtable is GRCU. The ticker symbol is used to trade Global Roundtable shares on the stock exchange.
Global Roundtable paid dividends every year for the past 0 years.
Global Roundtable is assigned to the 'Non-cyclical consumption' sector.
The dividends of Global Roundtable are distributed in USD.
Global Roundtable stock
Global Roundtable Peer Group
Global Roundtable Ticker
Global Roundtable FIGI
All fundamentals and in-depth analysis of Global Roundtable
Our stock analysis for Global Roundtable stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Global Roundtable. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.